on 12 Sep 2023
Last Applicant/ Owned by
Granta Park
GB
Serial Number
79337972 filed on 25th Feb 2022
Registration Number
7159597 registered on 12th Sep 2023
Correspondent Address
Andrew D. Price and Paula E. Hopkins
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chrRead More
Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; information, consultancy and advisory services relating to the aforesaid
Pharmaceuticals, namely, preparations and products for use in the treatment and prevention of disease in the field of oncology for both solid and liquid tumours, for use in the treatment and prevention of metabolic disease, urology and renal disease, in the cardiovascular field, in the field of hematology, for use in the treatment and prevention of respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders
No 79337972
No Service Mark
No 571390
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 02th Jan 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 13th Dec 2023 | FINAL DISPOSITION PROCESSED |
| 13th Dec 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 12th Dec 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 01st Dec 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| 12th Sep 2023 | REGISTERED-PRINCIPAL REGISTER |
| 12th Sep 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 27th Jun 2023 | PUBLISHED FOR OPPOSITION |
| 27th Jun 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 25th Jun 2023 | NOTIFICATION PROCESSED BY IB |
